Status:

COMPLETED

Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction

Lead Sponsor:

University of California, San Francisco

Conditions:

Nicotine Dependence

Tobacco Use Disorder

Eligibility:

All Genders

18-70 years

Brief Summary

This is a 2-year study involving the progressive reduction in the nicotine content of cigarettes. The investigators believe that at the end of the study smokers of cigarettes with progressively reduce...

Detailed Description

This is a 2-year, randomized, two-arm study involving a 6-month period of progressive reduction in the nicotine content of cigarettes. During the first year (tapering/maintenance phases), subjects wil...

Eligibility Criteria

Inclusion

  • Healthy on the basis of medical history and screening blood tests
  • Current moderate-to-heavy smoker as determined by:
  • smoking more than 10 cigarettes per day regularly for the past year (by history); and
  • expired carbon monoxide (CO) at screening visit of 25 ppm or more and/or plasma cotinine level of 100 ng/ml or more.
  • Age 18-70 years
  • Any racial/ethnic background

Exclusion

  • Expressed desire to quit smoking within 6 months.
  • Significant medical conditions (such as anemia, heart disease, uncontrolled hypertension, thyroid disease, diabetes, renal or liver impairment, glaucoma, or prostatic hypertrophy) or psychiatric condition (such as current major depression, history of schizophrenia or bipolar disorder, or current regular use of psychiatric medications such as major tranquilizers and antidepressants). Smokers with uncomplicated controlled hypertension may be enrolled.
  • Pregnancy or lactation (by history)
  • Current use of smokeless tobacco, pipes or cigars
  • Alcohol abuse or illicit drug use (by history)
  • Concurrent participation in another clinical trial or prior participation in our pilot studies using the same RNC cigarettes as in these studies

Key Trial Info

Start Date :

July 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

135 Patients enrolled

Trial Details

Trial ID

NCT00264342

Start Date

July 1 2005

End Date

July 1 2010

Last Update

May 23 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94110